Literature DB >> 6145675

Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.

A Stoudemire, J S Luther.   

Abstract

The clinical manifestations, differential diagnosis, and treatment of the neuroleptic malignant syndrome and neuroleptic-induced catatonia are discussed. A case is presented in which the catatonic-like behavior and extrapyramidal sequelae of the neuroleptic malignant syndrome responded to combined treatment with anticholinergics and levodopa/carbidopa. Differential diagnosis and theories regarding the development of these neuroleptic-induced disorders are reviewed.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6145675     DOI： 10.2190/lxd2-jtxj-3lpq-9pdn

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN： 0091-2174            Impact factor:   1.210


  5 in total

1.  Neuroleptic malignant syndrome and the catatonic dilemma.

Authors:  Stanley N Caroff; Stephan C Mann; E Cabrina Campbell
Journal:  Psychopharmacology (Berl)       Date:  2015-01-16       Impact factor: 4.530

2.  Haloperidol-induced neuroleptic malignant syndrome in a 67-year-old woman with parkinsonism.

Authors:  T C Ryken; A N Merrell
Journal:  West J Med       Date:  1989-09

Review 3.  Aetiology and treatment of neuroleptic malignant syndrome.

Authors:  C Harpe; A Stoudemire
Journal:  Med Toxicol       Date:  1987 May-Jun

4.  Neuroleptic malignant syndrome: a diagnostic dilemma.

Authors:  S M Sagar
Journal:  J R Soc Med       Date:  1991-08       Impact factor: 18.000

5.  Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients.

Authors:  Pradyot Sarkar; Chandrashekhar Natarajan; Neeta Gode
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.